BackAL: What psilocybin taught me about dying. J Palliat Med, 2019; 22:861–862.
2.
GriffithsR, RichardsW, JohnsonM, McCannU, JesseR: Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol, 2008; 22:621–632.
3.
GriffithsRR, JohnsonMW, RichardsWA, et al.: Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology (Berl), 2011; 218:649–665.
4.
GriffithsRR, RichardsWA, McCannU, JesseR: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl), 2006; 187:268–283; discussion 284–292.
5.
SwiftTC, BelserAB, Agin-LiebesG, et al.: Cancer at the dinner table: Experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. J Humanistic Psychol, 2017; 57:002216781771596.
6.
TurtonS, NuttDJ, Carhart-HarrisRL: A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. Curr Drug Abuse Rev, 2014; 7:117–127.
7.
FarbN, DaubenmierJ, PriceCJ, et al.: Interoception, contemplative practice, and health. Front Psychol, 2015; 6:763.
8.
EriksonEH, EriksonJM: The Life Cycle Completed. New York: W. W. Norton & Company, 1998.
